Leukotrienes and the Pulmonary Vascular Bed

  • Laurence Walch
  • Xavier Norel
  • Jean-Pierre Gascard
  • Charles Brink
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 507)


The antigenic stimulation of respiratory tissues has always been associated with the release of slow reacting substance of anaphylaxis (SRS-A), an entity which is now known to be a composite of metabolites of the 5-lipoxygenase enzymatic pathway, namely, the cysteinyl-leukotrienes (LTC4, LTD4 and LTE4). Evidence that these mediators may play a role in asthma was based on the clinical observations that several cell types that produce cysteinyl-leukotrienes are present in increased numbers in the lung of asthmatic patients. Furthermore, these metabolites were detected in biological fluids derived from asthmatics following allergen inhalation. Such clinical data implicated the cysteinyl-leukotrienes in not only the allergic reactions to inhaled allergens but also supported the notion that these mediators may play a role in asthma.


Pulmonary Artery Pulmonary Vein Vascular Preparation Arterial Preparation Contractile Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gorenne I, Labat C, Gascard J-P, Brink C. Antigen stimulation of human pulmonary smooth muscle: an in vitro model of inflammation. Cell Biol Toxicol 1996; 12: 239–244.PubMedCrossRefGoogle Scholar
  2. 2.
    Alexander DI, Eyre P, Gordon VP. Anaphylactic contraction (Schultz-Dale reaction) of the bovine bronchial artery in vitro. Br J Pharmacol 1983; 80: 7–9.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Hand JM, Buckner CK. Effects of selective antagonists on ovalbumin induced contraction of tracheal strips isolated from the actively sensitized guinea pig. lit J Immunopharmacol 1979; 1: 189–195.CrossRefGoogle Scholar
  4. 4.
    Hand JM, Will JA, Buckner CK. Effects of leukotrienes on isolated guinea pig pulmonary arteries. Eur J Pharmacol 1981a; 76: 439–442.CrossRefGoogle Scholar
  5. 5.
    Hand JM, Will JA, Buckner CK. Pharmacological alteration of antigen induced contraction of pulmonary arteries isolated from the actively sensitized guinea pig. J Pharmacol Exp Ther 198lb; 220: 526–535.Google Scholar
  6. 6.
    Kelly LJ, Undem BJ, Adams GK. Antigen induced contraction of guinea pig isolated pulmonary arteries and lung parenchyma. JAppl Physiol 1993; 74: 1563–1569.Google Scholar
  7. 7.
    Ortiz JL, Labat C, Norel X, Gorenne I, Verley J, Brink C. Response to anti-human IgE in human pulmonary arteries: regulation by the endothelium. Am Rev Respir Dis 1993; 147: 1029–1033.PubMedCrossRefGoogle Scholar
  8. 8.
    IUPHAR TiPS Suppl. 1995. XXXReceptor and ion channel nomenclature supplement. 15: pp.42–43.Google Scholar
  9. 9.
    Labat C, Ortiz JL, Norel X, Gorenne I, Verley J, Abrams TS, Cuthbert NJ, Tudhope SR, Norman P, Gardiner Pi, Brink C. A second cysteinyl leukotriene receptor in human lung. J Pharmacol Exp Ther 1992; 263: 800–805.PubMedGoogle Scholar
  10. 10.
    Rinkema LE, Roman CR, VanAlstyne EL, Spaethe SM, Fleisch JH. Contraction of guinea pig inferior vena cava by eicosanoids. Naunyn Schmiedebergs Arch Pharmacol 1993; 348: 520–525.PubMedCrossRefGoogle Scholar
  11. 11.
    Sakuma I, Gross SS, Levi R. Peptidoleukotrienes induced an endothelium-dependent relaxation of guinea pig main pulmonary artery and thoracic aorta. Prostaglandins 1987; 34: 685–696.PubMedCrossRefGoogle Scholar
  12. 12.
    Sakuma I, Levi R. Vasomotor effects of leukotrienes C4 and D4 on cavian pulmonary artery and aorta. Ann NYAcad Sci 1988; 524: 91–102.CrossRefGoogle Scholar
  13. 13.
    Pawloski JR, Chapwick BM. Antagonism of LTD4 evoked relaxation in canine renal artery and vein. Am J Physiol 1993; 265: 980–985.Google Scholar
  14. 14.
    Gorenne I, Norel X, Brink C. Cysteinyl-leukotriene receptors in the human lung: what’s new? TiPS. 1996; 17: 342–345.PubMedGoogle Scholar
  15. 15.
    Walch, L, Norel X, Gascard J-P, Brink C. Cysteinyl-leukotriene receptors in pulmonary vessels. J Physiol Pharmacol 1999; 50: 567–573.PubMedGoogle Scholar
  16. 16.
    Ortiz JL, Gorenne I, Cortijo J, Seller A, Labat C, Sarria B, Abram TS, Gardiner PJ, Morcillo E, Brink C. Leukotriene receptors on human pulmonary vascular endothelium. Br J Pharmacol 1995; 115: 1382–86.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Félétou M, Girard V, Canet E. Different involvement of nitric oxide in endothelium dependent relaxation of porcine pulmonary artery and vein: influence of hypoxia. J Cardiovasc Pharmacol 1995; 25: 665–673.PubMedCrossRefGoogle Scholar
  18. 18.
    Goa Y, Zhou H, Raj JU. Endothelium derived nitric oxide plays a larger role in pulmonary veins than in arteries of newborn lambs. Circ. Res. 1995; 76: 559–565.Google Scholar
  19. 19.
    Wallerstedt SM, Bodelsson M, Endothelium dependent relaxation by substance P in human isolated omental arteries and veins: relative contribution of prostanoids, nitric oxide and hypertension. Br J Pharmacol 1997; 120: 25–30.PubMedCrossRefGoogle Scholar
  20. 20.
    Allen SP, Chester AH, Piper PJ, Sampson AP, Aid ESK, Yacoub MH. Effects of leukotrienes C4 and D4 on human isolated saphenous veins. Br J Clin Pharmacol 1992; 34: 409–414.PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Laurence Walch
    • 1
  • Xavier Norel
    • 1
  • Jean-Pierre Gascard
    • 1
  • Charles Brink
    • 1
  1. 1.Centre Chirurgical Marie LannelongueCNRS ESA 8078Le Plessis RobinsonFrance

Personalised recommendations